Conception.bio focuses on improving fertility treatments through advanced biotechnology. The company has developed a method to create viable egg cells from blood samples by transforming induced pluripotent stem cells (iPSCs) into mature egg cells. This process allows women to extend their fertility, provides options for couples facing infertility, and supports same-sex male couples wanting biological children. Unlike many competitors, Conception.bio emphasizes a collaborative research environment with a team of skilled scientists dedicated to fertility science. The goal is to offer effective solutions for infertility and enhance reproductive health, making it easier for individuals and couples to achieve their family planning goals.